nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—Conjugated Estrogens—prostate cancer	0.126	0.388	CbGbCtD
Valaciclovir—SLC22A8—Estradiol—prostate cancer	0.111	0.341	CbGbCtD
Valaciclovir—SLC22A6—Conjugated Estrogens—prostate cancer	0.0878	0.271	CbGbCtD
Valaciclovir—SLC22A8—urine—prostate cancer	0.00593	0.226	CbGeAlD
Valaciclovir—SLC10A2—renal system—prostate cancer	0.0052	0.198	CbGeAlD
Valaciclovir—Ganciclovir—SLC22A1—prostate cancer	0.00319	0.562	CrCbGaD
Valaciclovir—Aciclovir—SLC22A1—prostate cancer	0.00248	0.437	CrCbGaD
Valaciclovir—SLC15A1—epithelium—prostate cancer	0.00218	0.0829	CbGeAlD
Valaciclovir—SLC22A8—prostate gland—prostate cancer	0.00213	0.0812	CbGeAlD
Valaciclovir—SLC15A1—renal system—prostate cancer	0.00202	0.0769	CbGeAlD
Valaciclovir—SLC15A2—prostate gland—prostate cancer	0.00185	0.0706	CbGeAlD
Valaciclovir—SLC15A2—seminal vesicle—prostate cancer	0.00157	0.0597	CbGeAlD
Valaciclovir—SLC22A8—renal system—prostate cancer	0.00145	0.0553	CbGeAlD
Valaciclovir—SLC15A2—renal system—prostate cancer	0.00126	0.0481	CbGeAlD
Valaciclovir—SLC15A2—urethra—prostate cancer	0.00124	0.0472	CbGeAlD
Valaciclovir—SLC15A2—testis—prostate cancer	0.000815	0.0311	CbGeAlD
Valaciclovir—SLC15A2—lymph node—prostate cancer	0.000591	0.0225	CbGeAlD
Valaciclovir—SLC10A2—Metabolism—HAO1—prostate cancer	0.000429	0.00229	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000429	0.00229	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000429	0.00229	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000415	0.00222	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000407	0.00218	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.0004	0.00214	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.0004	0.00214	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.0004	0.00214	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000399	0.00213	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000399	0.00213	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.000384	0.00205	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00038	0.00203	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000371	0.00198	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000371	0.00198	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.000369	0.00197	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.000357	0.00191	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000351	0.00188	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CSAD—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TST—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CBR1—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSAT1—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GRHL1—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADI1—prostate cancer	0.00035	0.00187	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000348	0.00186	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000346	0.00185	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.000342	0.00183	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.000335	0.00179	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00033	0.00176	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00033	0.00176	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CKMT2—prostate cancer	0.000325	0.00174	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UGT2B15—prostate cancer	0.000325	0.00174	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UGT2B17—prostate cancer	0.000325	0.00174	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GRHPR—prostate cancer	0.000325	0.00174	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000324	0.00173	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000323	0.00173	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000321	0.00172	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.000318	0.0017	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.000313	0.00167	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.00031	0.00166	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PGAM2—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MBTPS1—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAGLU—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SULT2B1—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AOX1—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM3—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—RFK—prostate cancer	0.000306	0.00163	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000301	0.00161	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.0003	0.0016	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000299	0.0016	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000295	0.00158	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP3A43—prostate cancer	0.00029	0.00155	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AMACR—prostate cancer	0.00029	0.00155	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—DEGS1—prostate cancer	0.00029	0.00155	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SRD5A2—prostate cancer	0.00029	0.00155	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAT1—prostate cancer	0.00029	0.00155	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000285	0.00152	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000284	0.00152	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.000283	0.00151	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD17B1—prostate cancer	0.000277	0.00148	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000277	0.00148	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000275	0.00147	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000275	0.00147	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00027	0.00144	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000267	0.00143	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000267	0.00143	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000266	0.00142	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000264	0.00141	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000264	0.00141	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000262	0.0014	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000255	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000251	0.00134	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000249	0.00133	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—B4GALT4—prostate cancer	0.000246	0.00132	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPGD—prostate cancer	0.000246	0.00132	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000245	0.00131	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000237	0.00127	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000237	0.00127	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TNFRSF21—prostate cancer	0.000232	0.00124	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00023	0.00123	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000226	0.00121	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTAP—prostate cancer	0.000225	0.0012	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP7B1—prostate cancer	0.000225	0.0012	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000223	0.00119	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000223	0.00119	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.00022	0.00118	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SULT1E1—prostate cancer	0.00022	0.00117	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SRD5A1—prostate cancer	0.00022	0.00117	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000218	0.00116	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000217	0.00116	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000211	0.00113	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.00021	0.00112	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACSL4—prostate cancer	0.00021	0.00112	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD17B3—prostate cancer	0.00021	0.00112	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000208	0.00111	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000207	0.00111	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000207	0.00111	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000203	0.00108	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000203	0.00108	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ARG2—prostate cancer	0.000201	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PHGDH—prostate cancer	0.000201	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UMPS—prostate cancer	0.000201	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LDHB—prostate cancer	0.000197	0.00105	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP3A5—prostate cancer	0.000193	0.00103	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000193	0.00103	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000193	0.00103	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.00019	0.00102	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000188	0.00101	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000188	0.00101	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TCN2—prostate cancer	0.000187	0.000998	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UCP3—prostate cancer	0.000187	0.000998	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PDHA1—prostate cancer	0.000187	0.000998	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA3—prostate cancer	0.000187	0.000998	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000183	0.000977	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000182	0.000972	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000179	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD3B1—prostate cancer	0.000178	0.000952	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC22A3—prostate cancer	0.000178	0.000952	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000176	0.00094	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000174	0.000929	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000173	0.000924	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000172	0.000918	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TBXAS1—prostate cancer	0.000171	0.000913	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA4—prostate cancer	0.000171	0.000913	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000167	0.000895	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000167	0.000895	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000167	0.000892	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA2—prostate cancer	0.000166	0.00089	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000165	0.000879	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG5—prostate cancer	0.000164	0.000879	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SULT1A1—prostate cancer	0.000164	0.000879	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA1—prostate cancer	0.000161	0.000858	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Docetaxel—prostate cancer	0.000159	0.000349	CcSEcCtD
Valaciclovir—Thrombocytopenia—Docetaxel—prostate cancer	0.000159	0.000349	CcSEcCtD
Valaciclovir—Rash—Estradiol—prostate cancer	0.000159	0.000349	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000159	0.00085	CbGpPWpGaD
Valaciclovir—Dermatitis—Estradiol—prostate cancer	0.000159	0.000348	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTO1—prostate cancer	0.000159	0.000849	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSD3B2—prostate cancer	0.000159	0.000849	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAT2—prostate cancer	0.000159	0.000849	CbGpPWpGaD
Valaciclovir—Anaemia—Prednisone—prostate cancer	0.000159	0.000348	CcSEcCtD
Valaciclovir—Confusional state—Capecitabine—prostate cancer	0.000159	0.000348	CcSEcCtD
Valaciclovir—Tachycardia—Docetaxel—prostate cancer	0.000159	0.000348	CcSEcCtD
Valaciclovir—Headache—Estradiol—prostate cancer	0.000158	0.000346	CcSEcCtD
Valaciclovir—Skin disorder—Docetaxel—prostate cancer	0.000158	0.000346	CcSEcCtD
Valaciclovir—Agitation—Prednisone—prostate cancer	0.000158	0.000346	CcSEcCtD
Valaciclovir—Oedema—Capecitabine—prostate cancer	0.000157	0.000345	CcSEcCtD
Valaciclovir—Angioedema—Prednisone—prostate cancer	0.000157	0.000344	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—prostate cancer	0.000156	0.000343	CcSEcCtD
Valaciclovir—Infection—Capecitabine—prostate cancer	0.000156	0.000343	CcSEcCtD
Valaciclovir—Urticaria—Etoposide—prostate cancer	0.000155	0.00034	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—prostate cancer	0.000155	0.00034	CcSEcCtD
Valaciclovir—Anorexia—Docetaxel—prostate cancer	0.000155	0.000339	CcSEcCtD
Valaciclovir—Rhinitis—Epirubicin—prostate cancer	0.000155	0.000339	CcSEcCtD
Valaciclovir—Body temperature increased—Etoposide—prostate cancer	0.000155	0.000339	CcSEcCtD
Valaciclovir—Abdominal pain—Etoposide—prostate cancer	0.000155	0.000339	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—prostate cancer	0.000155	0.000339	CcSEcCtD
Valaciclovir—Nervous system disorder—Capecitabine—prostate cancer	0.000154	0.000338	CcSEcCtD
Valaciclovir—Hepatitis—Epirubicin—prostate cancer	0.000154	0.000338	CcSEcCtD
Valaciclovir—Thrombocytopenia—Capecitabine—prostate cancer	0.000154	0.000338	CcSEcCtD
Valaciclovir—Tachycardia—Capecitabine—prostate cancer	0.000154	0.000336	CcSEcCtD
Valaciclovir—Pharyngitis—Epirubicin—prostate cancer	0.000153	0.000336	CcSEcCtD
Valaciclovir—Skin disorder—Capecitabine—prostate cancer	0.000153	0.000335	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000153	0.000816	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000153	0.000816	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Epirubicin—prostate cancer	0.000152	0.000334	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PLCB2—prostate cancer	0.000152	0.000814	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2C18—prostate cancer	0.000152	0.000814	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LRP2—prostate cancer	0.000152	0.000814	CbGpPWpGaD
Valaciclovir—Oedema peripheral—Epirubicin—prostate cancer	0.000152	0.000333	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000152	0.000812	CbGpPWpGaD
Valaciclovir—Haematuria—Doxorubicin—prostate cancer	0.000152	0.000332	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—prostate cancer	0.000151	0.000331	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—prostate cancer	0.00015	0.00033	CcSEcCtD
Valaciclovir—Anorexia—Capecitabine—prostate cancer	0.00015	0.000329	CcSEcCtD
Valaciclovir—Nausea—Estradiol—prostate cancer	0.00015	0.000328	CcSEcCtD
Valaciclovir—Vomiting—Mitoxantrone—prostate cancer	0.000149	0.000328	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—P4HB—prostate cancer	0.000149	0.000798	CbGpPWpGaD
Valaciclovir—Sinusitis—Doxorubicin—prostate cancer	0.000149	0.000327	CcSEcCtD
Valaciclovir—Convulsion—Prednisone—prostate cancer	0.000149	0.000326	CcSEcCtD
Valaciclovir—Hypertension—Prednisone—prostate cancer	0.000148	0.000325	CcSEcCtD
Valaciclovir—Rash—Mitoxantrone—prostate cancer	0.000148	0.000325	CcSEcCtD
Valaciclovir—Dermatitis—Mitoxantrone—prostate cancer	0.000148	0.000324	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000148	0.000324	CcSEcCtD
Valaciclovir—Headache—Mitoxantrone—prostate cancer	0.000147	0.000323	CcSEcCtD
Valaciclovir—Insomnia—Docetaxel—prostate cancer	0.000147	0.000322	CcSEcCtD
Valaciclovir—Myalgia—Prednisone—prostate cancer	0.000146	0.00032	CcSEcCtD
Valaciclovir—Arthralgia—Prednisone—prostate cancer	0.000146	0.00032	CcSEcCtD
Valaciclovir—Paraesthesia—Docetaxel—prostate cancer	0.000146	0.00032	CcSEcCtD
Valaciclovir—Erythema multiforme—Epirubicin—prostate cancer	0.000146	0.00032	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC22A1—prostate cancer	0.000145	0.000776	CbGpPWpGaD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000145	0.000318	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000145	0.000776	CbGpPWpGaD
Valaciclovir—Dyspnoea—Docetaxel—prostate cancer	0.000145	0.000317	CcSEcCtD
Valaciclovir—Somnolence—Docetaxel—prostate cancer	0.000144	0.000317	CcSEcCtD
Valaciclovir—Hypersensitivity—Etoposide—prostate cancer	0.000144	0.000316	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000144	0.000767	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000143	0.000766	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000143	0.000314	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—prostate cancer	0.000143	0.000314	CcSEcCtD
Valaciclovir—Dyspepsia—Docetaxel—prostate cancer	0.000143	0.000313	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—prostate cancer	0.000143	0.000313	CcSEcCtD
Valaciclovir—Insomnia—Capecitabine—prostate cancer	0.000142	0.000312	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—prostate cancer	0.000142	0.00031	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SULT2A1—prostate cancer	0.000142	0.000756	CbGpPWpGaD
Valaciclovir—Paraesthesia—Capecitabine—prostate cancer	0.000141	0.00031	CcSEcCtD
Valaciclovir—Decreased appetite—Docetaxel—prostate cancer	0.000141	0.00031	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—prostate cancer	0.000141	0.000309	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000141	0.000753	CbGpPWpGaD
Valaciclovir—Oedema peripheral—Doxorubicin—prostate cancer	0.000141	0.000308	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Dyspnoea—Capecitabine—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Oedema—Prednisone—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Anaphylactic shock—Prednisone—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Fatigue—Docetaxel—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—prostate cancer	0.00014	0.000307	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00014	0.000747	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00014	0.000747	CbGpPWpGaD
Valaciclovir—Nausea—Mitoxantrone—prostate cancer	0.00014	0.000306	CcSEcCtD
Valaciclovir—Immune system disorder—Epirubicin—prostate cancer	0.000139	0.000305	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—MED12—prostate cancer	0.000139	0.000744	CbGpPWpGaD
Valaciclovir—Infection—Prednisone—prostate cancer	0.000139	0.000305	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—prostate cancer	0.000139	0.000305	CcSEcCtD
Valaciclovir—Constipation—Docetaxel—prostate cancer	0.000139	0.000305	CcSEcCtD
Valaciclovir—Pain—Docetaxel—prostate cancer	0.000139	0.000305	CcSEcCtD
Valaciclovir—Dyspepsia—Capecitabine—prostate cancer	0.000139	0.000303	CcSEcCtD
Valaciclovir—Chills—Epirubicin—prostate cancer	0.000138	0.000303	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—prostate cancer	0.000138	0.000303	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GNG5—prostate cancer	0.000138	0.000738	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Prednisone—prostate cancer	0.000137	0.000301	CcSEcCtD
Valaciclovir—Tachycardia—Prednisone—prostate cancer	0.000137	0.0003	CcSEcCtD
Valaciclovir—Decreased appetite—Capecitabine—prostate cancer	0.000137	0.0003	CcSEcCtD
Valaciclovir—Alopecia—Epirubicin—prostate cancer	0.000136	0.000299	CcSEcCtD
Valaciclovir—Skin disorder—Prednisone—prostate cancer	0.000136	0.000298	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000136	0.000298	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000136	0.000726	CbGpPWpGaD
Valaciclovir—Fatigue—Capecitabine—prostate cancer	0.000136	0.000297	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—prostate cancer	0.000135	0.000296	CcSEcCtD
Valaciclovir—Constipation—Capecitabine—prostate cancer	0.000135	0.000295	CcSEcCtD
Valaciclovir—Pain—Capecitabine—prostate cancer	0.000135	0.000295	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000134	0.000717	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Docetaxel—prostate cancer	0.000134	0.000293	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—prostate cancer	0.000134	0.000293	CcSEcCtD
Valaciclovir—Anorexia—Prednisone—prostate cancer	0.000134	0.000293	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA3—prostate cancer	0.000133	0.000711	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Docetaxel—prostate cancer	0.000133	0.000291	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000133	0.00071	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000133	0.000709	CbGpPWpGaD
Valaciclovir—Flatulence—Epirubicin—prostate cancer	0.000132	0.00029	CcSEcCtD
Valaciclovir—Tension—Epirubicin—prostate cancer	0.000132	0.000289	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000131	0.000699	CbGpPWpGaD
Valaciclovir—Nervousness—Epirubicin—prostate cancer	0.00013	0.000286	CcSEcCtD
Valaciclovir—Back pain—Epirubicin—prostate cancer	0.00013	0.000285	CcSEcCtD
Valaciclovir—Feeling abnormal—Capecitabine—prostate cancer	0.00013	0.000284	CcSEcCtD
Valaciclovir—Dizziness—Etoposide—prostate cancer	0.000129	0.000283	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—prostate cancer	0.000129	0.000283	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Capecitabine—prostate cancer	0.000129	0.000282	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—prostate cancer	0.000129	0.000282	CcSEcCtD
Valaciclovir—Body temperature increased—Docetaxel—prostate cancer	0.000128	0.000281	CcSEcCtD
Valaciclovir—Abdominal pain—Docetaxel—prostate cancer	0.000128	0.000281	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—prostate cancer	0.000128	0.000281	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000128	0.00028	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000128	0.000682	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPGDS—prostate cancer	0.000127	0.000678	CbGpPWpGaD
Valaciclovir—Insomnia—Prednisone—prostate cancer	0.000127	0.000278	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—prostate cancer	0.000126	0.000276	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP2C19—prostate cancer	0.000126	0.000674	CbGpPWpGaD
Valaciclovir—Paraesthesia—Prednisone—prostate cancer	0.000126	0.000276	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000125	0.00067	CbGpPWpGaD
Valaciclovir—Urticaria—Capecitabine—prostate cancer	0.000125	0.000274	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000125	0.000665	CbGpPWpGaD
Valaciclovir—Abdominal pain—Capecitabine—prostate cancer	0.000124	0.000273	CcSEcCtD
Valaciclovir—Body temperature increased—Capecitabine—prostate cancer	0.000124	0.000273	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—prostate cancer	0.000124	0.000272	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—prostate cancer	0.000124	0.000272	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—prostate cancer	0.000123	0.00027	CcSEcCtD
Valaciclovir—Dyspepsia—Prednisone—prostate cancer	0.000123	0.00027	CcSEcCtD
Valaciclovir—Rash—Etoposide—prostate cancer	0.000123	0.00027	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—prostate cancer	0.000123	0.00027	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTT1—prostate cancer	0.000123	0.000658	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACHE—prostate cancer	0.000123	0.000658	CbGpPWpGaD
Valaciclovir—Headache—Etoposide—prostate cancer	0.000123	0.000268	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—prostate cancer	0.000122	0.000268	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—prostate cancer	0.000122	0.000267	CcSEcCtD
Valaciclovir—Decreased appetite—Prednisone—prostate cancer	0.000122	0.000267	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP2A6—prostate cancer	0.000122	0.00065	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000121	0.000648	CbGpPWpGaD
Valaciclovir—Fatigue—Prednisone—prostate cancer	0.000121	0.000265	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—prostate cancer	0.000121	0.000264	CcSEcCtD
Valaciclovir—Leukopenia—Epirubicin—prostate cancer	0.00012	0.000263	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—prostate cancer	0.00012	0.000263	CcSEcCtD
Valaciclovir—Constipation—Prednisone—prostate cancer	0.00012	0.000263	CcSEcCtD
Valaciclovir—Hypersensitivity—Docetaxel—prostate cancer	0.00012	0.000262	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000118	0.000633	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKR1C3—prostate cancer	0.000118	0.000633	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PRKACB—prostate cancer	0.000118	0.000629	CbGpPWpGaD
Valaciclovir—Cough—Epirubicin—prostate cancer	0.000117	0.000257	CcSEcCtD
Valaciclovir—Asthenia—Docetaxel—prostate cancer	0.000117	0.000255	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP17A1—prostate cancer	0.000117	0.000623	CbGpPWpGaD
Valaciclovir—Convulsion—Epirubicin—prostate cancer	0.000116	0.000255	CcSEcCtD
Valaciclovir—Nausea—Etoposide—prostate cancer	0.000116	0.000255	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—prostate cancer	0.000116	0.000254	CcSEcCtD
Valaciclovir—Hypersensitivity—Capecitabine—prostate cancer	0.000116	0.000254	CcSEcCtD
Valaciclovir—Feeling abnormal—Prednisone—prostate cancer	0.000116	0.000253	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000115	0.000616	CbGpPWpGaD
Valaciclovir—Pruritus—Docetaxel—prostate cancer	0.000115	0.000252	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Valaciclovir—Anaemia—Doxorubicin—prostate cancer	0.000115	0.000252	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Prednisone—prostate cancer	0.000115	0.000251	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—prostate cancer	0.000114	0.000251	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—prostate cancer	0.000114	0.000251	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—prostate cancer	0.000114	0.000251	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—prostate cancer	0.000114	0.00025	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000114	0.000249	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000113	0.000606	CbGpPWpGaD
Valaciclovir—Asthenia—Capecitabine—prostate cancer	0.000113	0.000247	CcSEcCtD
Valaciclovir—Dry mouth—Epirubicin—prostate cancer	0.000112	0.000245	CcSEcCtD
Valaciclovir—Urticaria—Prednisone—prostate cancer	0.000111	0.000244	CcSEcCtD
Valaciclovir—Pruritus—Capecitabine—prostate cancer	0.000111	0.000244	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—prostate cancer	0.000111	0.000244	CcSEcCtD
Valaciclovir—Diarrhoea—Docetaxel—prostate cancer	0.000111	0.000244	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA2—prostate cancer	0.000111	0.000594	CbGpPWpGaD
Valaciclovir—Abdominal pain—Prednisone—prostate cancer	0.000111	0.000243	CcSEcCtD
Valaciclovir—Body temperature increased—Prednisone—prostate cancer	0.000111	0.000243	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000111	0.000592	CbGpPWpGaD
Valaciclovir—Confusional state—Epirubicin—prostate cancer	0.000111	0.000242	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—prostate cancer	0.00011	0.00024	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—prostate cancer	0.00011	0.00024	CcSEcCtD
Valaciclovir—Infection—Epirubicin—prostate cancer	0.000109	0.000239	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000109	0.000581	CbGpPWpGaD
Valaciclovir—Cough—Doxorubicin—prostate cancer	0.000108	0.000238	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—prostate cancer	0.000108	0.000236	CcSEcCtD
Valaciclovir—Diarrhoea—Capecitabine—prostate cancer	0.000108	0.000236	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—prostate cancer	0.000108	0.000236	CcSEcCtD
Valaciclovir—Dizziness—Docetaxel—prostate cancer	0.000107	0.000235	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—prostate cancer	0.000107	0.000235	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—prostate cancer	0.000107	0.000235	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—prostate cancer	0.000107	0.000234	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—prostate cancer	0.000106	0.000233	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC5A5—prostate cancer	0.000106	0.000566	CbGpPWpGaD
Valaciclovir—Arthralgia—Doxorubicin—prostate cancer	0.000106	0.000232	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—prostate cancer	0.000106	0.000232	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—prostate cancer	0.000106	0.000232	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000105	0.000563	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000105	0.000563	CbGpPWpGaD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000105	0.00023	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000105	0.000559	CbGpPWpGaD
Valaciclovir—Anorexia—Epirubicin—prostate cancer	0.000105	0.000229	CcSEcCtD
Valaciclovir—Dizziness—Capecitabine—prostate cancer	0.000104	0.000228	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP2E1—prostate cancer	0.000104	0.000553	CbGpPWpGaD
Valaciclovir—Dry mouth—Doxorubicin—prostate cancer	0.000103	0.000227	CcSEcCtD
Valaciclovir—Vomiting—Docetaxel—prostate cancer	0.000103	0.000226	CcSEcCtD
Valaciclovir—Hypersensitivity—Prednisone—prostate cancer	0.000103	0.000226	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000103	0.000548	CbGpPWpGaD
Valaciclovir—Rash—Docetaxel—prostate cancer	0.000102	0.000225	CcSEcCtD
Valaciclovir—Dermatitis—Docetaxel—prostate cancer	0.000102	0.000224	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NQO1—prostate cancer	0.000102	0.000547	CbGpPWpGaD
Valaciclovir—Confusional state—Doxorubicin—prostate cancer	0.000102	0.000224	CcSEcCtD
Valaciclovir—Headache—Docetaxel—prostate cancer	0.000102	0.000223	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—prostate cancer	0.000101	0.000222	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—prostate cancer	0.000101	0.000222	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000101	0.00054	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TH—prostate cancer	0.000101	0.000539	CbGpPWpGaD
Valaciclovir—Infection—Doxorubicin—prostate cancer	0.000101	0.000221	CcSEcCtD
Valaciclovir—Asthenia—Prednisone—prostate cancer	0.000101	0.00022	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.0001	0.000535	CbGpPWpGaD
Valaciclovir—Vomiting—Capecitabine—prostate cancer	0.0001	0.000219	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—prostate cancer	9.99e-05	0.000219	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP3A4—prostate cancer	9.98e-05	0.000533	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Doxorubicin—prostate cancer	9.95e-05	0.000218	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—prostate cancer	9.93e-05	0.000218	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	9.93e-05	0.000531	CbGpPWpGaD
Valaciclovir—Rash—Capecitabine—prostate cancer	9.92e-05	0.000217	CcSEcCtD
Valaciclovir—Pruritus—Prednisone—prostate cancer	9.92e-05	0.000217	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—prostate cancer	9.92e-05	0.000217	CcSEcCtD
Valaciclovir—Dermatitis—Capecitabine—prostate cancer	9.91e-05	0.000217	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—prostate cancer	9.9e-05	0.000217	CcSEcCtD
Valaciclovir—Headache—Capecitabine—prostate cancer	9.86e-05	0.000216	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—prostate cancer	9.85e-05	0.000216	CcSEcCtD
Valaciclovir—Paraesthesia—Epirubicin—prostate cancer	9.84e-05	0.000216	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP1B1—prostate cancer	9.81e-05	0.000524	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.79e-05	0.000523	CbGpPWpGaD
Valaciclovir—Dyspnoea—Epirubicin—prostate cancer	9.77e-05	0.000214	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—prostate cancer	9.75e-05	0.000214	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—prostate cancer	9.67e-05	0.000212	CcSEcCtD
Valaciclovir—Nausea—Docetaxel—prostate cancer	9.65e-05	0.000212	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—prostate cancer	9.65e-05	0.000211	CcSEcCtD
Valaciclovir—Diarrhoea—Prednisone—prostate cancer	9.59e-05	0.00021	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—prostate cancer	9.53e-05	0.000209	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.52e-05	0.000509	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GGT1—prostate cancer	9.5e-05	0.000508	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Epirubicin—prostate cancer	9.46e-05	0.000207	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—prostate cancer	9.45e-05	0.000207	CcSEcCtD
Valaciclovir—Pain—Epirubicin—prostate cancer	9.37e-05	0.000205	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—prostate cancer	9.37e-05	0.000205	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA1—prostate cancer	9.36e-05	0.0005	CbGpPWpGaD
Valaciclovir—Nausea—Capecitabine—prostate cancer	9.35e-05	0.000205	CcSEcCtD
Valaciclovir—Dizziness—Prednisone—prostate cancer	9.27e-05	0.000203	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.24e-05	0.000494	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.24e-05	0.000202	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP19A1—prostate cancer	9.23e-05	0.000493	CbGpPWpGaD
Valaciclovir—Insomnia—Doxorubicin—prostate cancer	9.17e-05	0.000201	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—prostate cancer	9.11e-05	0.0002	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.08e-05	0.000485	CbGpPWpGaD
Valaciclovir—Dyspnoea—Doxorubicin—prostate cancer	9.04e-05	0.000198	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—prostate cancer	9.03e-05	0.000198	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—prostate cancer	9.02e-05	0.000198	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	8.98e-05	0.00048	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Epirubicin—prostate cancer	8.96e-05	0.000196	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—prostate cancer	8.93e-05	0.000196	CcSEcCtD
Valaciclovir—Vomiting—Prednisone—prostate cancer	8.91e-05	0.000195	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—RXRA—prostate cancer	8.9e-05	0.000476	CbGpPWpGaD
Valaciclovir—Rash—Prednisone—prostate cancer	8.84e-05	0.000194	CcSEcCtD
Valaciclovir—Dermatitis—Prednisone—prostate cancer	8.83e-05	0.000193	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—prostate cancer	8.82e-05	0.000193	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	8.79e-05	0.00047	CbGpPWpGaD
Valaciclovir—Headache—Prednisone—prostate cancer	8.78e-05	0.000192	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.76e-05	0.000192	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—prostate cancer	8.75e-05	0.000192	CcSEcCtD
Valaciclovir—Urticaria—Epirubicin—prostate cancer	8.71e-05	0.000191	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—prostate cancer	8.67e-05	0.00019	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—prostate cancer	8.67e-05	0.00019	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—prostate cancer	8.67e-05	0.00019	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—prostate cancer	8.67e-05	0.00019	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.66e-05	0.000463	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.65e-05	0.000462	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—COMT—prostate cancer	8.58e-05	0.000458	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—prostate cancer	8.54e-05	0.000456	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	8.47e-05	0.000453	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ITPR1—prostate cancer	8.4e-05	0.000449	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Doxorubicin—prostate cancer	8.36e-05	0.000183	CcSEcCtD
Valaciclovir—Nausea—Prednisone—prostate cancer	8.33e-05	0.000182	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—prostate cancer	8.29e-05	0.000182	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.26e-05	0.000441	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	8.22e-05	0.000439	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	8.08e-05	0.000432	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Epirubicin—prostate cancer	8.08e-05	0.000177	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—prostate cancer	8.06e-05	0.000177	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.02e-05	0.000429	CbGpPWpGaD
Valaciclovir—Body temperature increased—Doxorubicin—prostate cancer	8.02e-05	0.000176	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—prostate cancer	8.02e-05	0.000176	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—TYMS—prostate cancer	7.94e-05	0.000424	CbGpPWpGaD
Valaciclovir—Asthenia—Epirubicin—prostate cancer	7.87e-05	0.000172	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTM1—prostate cancer	7.84e-05	0.000419	CbGpPWpGaD
Valaciclovir—Pruritus—Epirubicin—prostate cancer	7.76e-05	0.00017	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—LPL—prostate cancer	7.7e-05	0.000411	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	7.63e-05	0.000408	CbGpPWpGaD
Valaciclovir—Diarrhoea—Epirubicin—prostate cancer	7.5e-05	0.000164	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.49e-05	0.0004	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Doxorubicin—prostate cancer	7.47e-05	0.000164	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP1A1—prostate cancer	7.44e-05	0.000397	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ERCC2—prostate cancer	7.37e-05	0.000394	CbGpPWpGaD
Valaciclovir—Asthenia—Doxorubicin—prostate cancer	7.28e-05	0.000159	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—prostate cancer	7.25e-05	0.000159	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—prostate cancer	7.18e-05	0.000157	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	7.14e-05	0.000381	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.07e-05	0.000378	CbGpPWpGaD
Valaciclovir—Vomiting—Epirubicin—prostate cancer	6.97e-05	0.000153	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—prostate cancer	6.94e-05	0.000152	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—MTHFR—prostate cancer	6.93e-05	0.00037	CbGpPWpGaD
Valaciclovir—Rash—Epirubicin—prostate cancer	6.91e-05	0.000151	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—prostate cancer	6.91e-05	0.000151	CcSEcCtD
Valaciclovir—Headache—Epirubicin—prostate cancer	6.87e-05	0.00015	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PPARA—prostate cancer	6.8e-05	0.000363	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	6.79e-05	0.000363	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.74e-05	0.00036	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—prostate cancer	6.71e-05	0.000147	CcSEcCtD
Valaciclovir—Nausea—Epirubicin—prostate cancer	6.51e-05	0.000143	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—prostate cancer	6.45e-05	0.000141	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—prostate cancer	6.4e-05	0.00014	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CAV1—prostate cancer	6.39e-05	0.000342	CbGpPWpGaD
Valaciclovir—Dermatitis—Doxorubicin—prostate cancer	6.39e-05	0.00014	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—prostate cancer	6.35e-05	0.000139	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	6.28e-05	0.000336	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.11e-05	0.000326	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—prostate cancer	6.03e-05	0.000132	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.96e-05	0.000318	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	5.83e-05	0.000312	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—prostate cancer	5.82e-05	0.000311	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	5.66e-05	0.000303	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—INS—prostate cancer	5.51e-05	0.000295	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CREBBP—prostate cancer	5.4e-05	0.000289	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	5.18e-05	0.000277	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—prostate cancer	5.12e-05	0.000274	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.99e-05	0.000267	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NOS3—prostate cancer	4.83e-05	0.000258	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.63e-05	0.000247	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—prostate cancer	4.46e-05	0.000238	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—prostate cancer	4.42e-05	0.000236	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	4.33e-05	0.000231	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.12e-05	0.00022	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—prostate cancer	3.86e-05	0.000206	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—EP300—prostate cancer	3.68e-05	0.000197	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.44e-05	0.000184	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—prostate cancer	2.72e-05	0.000145	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—prostate cancer	2.22e-05	0.000119	CbGpPWpGaD
